Health Products

Co-Quetiapine 100 mg

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety, Contamination
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
More than 10 numbers, contact manufacturer.A. Co-Quetiapine 100 mg
Recalling Firm
Cobalt Pharmaceuticals Inc.
6500 Kitimat Road,
Mississauga
L5N 2B8
Ontario
CANADA
Marketing Authorization Holder
Cobalt Pharmaceuticals Inc.
6500 Kitimat Road,
Mississauga
L5N 2B8
Ontario
CANADA
TabletsDIN 02316099100 mg / tablet

Introduction

Recalled products
  1. Co-Quetiapine 100 mg

Reason

Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.

Depth of distribution

Product distributed to wholesalers and pharmacies across Canada
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime